- Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
-
Jongmoo Park, Jae Won Park, Min Kyu Kang
-
Yeungnam Univ J Med. 2019;36(3):192-200. Published online August 12, 2019
-
DOI: https://doi.org/10.12701/yujm.2019.00269
-
-
7,043
View
-
129
Download
-
2
Citations
-
 Abstract
 PDF
- Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help of advanced modern RT and imaging technologies. Currently, SBRT is recommended as an alternative to curative treatments, such as surgery and radiofrequency ablation. This review discusses the current status of SBRT to aid in the decision making on how it is incorporated into the HCC management.
-
Citations
Citations to this article as recorded by  - MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review
Mohanned Alnammi, Jeremy Wortman, Jaclyn Therrien, Jalil Afnan
Abdominal Radiology.2022; 47(7): 2299. CrossRef - Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis
Shan Jin, Shisheng Tan, Wen Peng, Ying Jiang, Chunshan Luo
World Journal of Surgical Oncology.2020;[Epub] CrossRef
|
E-Submission
Yeungnam University College of Medicine
